Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Heartbeam Inc. Warrant (BEATW:NASDAQ), powered by AI.
Heartbeam Inc. Warrant is currently trading at $0.04. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Heartbeam Inc. Warrant on Alpha Lenz.
View Heartbeam Inc. Warrant's valuation metrics on Alpha Lenz.
“Heartbeam Inc. Warrant's ROE is -987.3%. Explore profitability and growth together.”
Ask for details →Heartbeam Inc. Warrant is a financial instrument that offers the right, but not the obligation, to purchase shares of Heartbeam Inc. at a predetermined price before an expiration date. These warrants are typically issued alongside equity offerings to attract investors by adding potential investment upside. Heartbeam Inc., focused on the healthcare and medical technology sectors, is notably involved in developing products and technologies for cardiac health management. The company's innovative solutions aim to provide accessible and effective diagnostic tools for heart-related conditions, potentially transforming the way patients receive care outside of traditional clinical settings. Thus, the warrants allow investors to participate in the potential growth of Heartbeam as it advances its technology and market presence, reflecting both confidence in the company's strategic direction and its impact on the healthcare industry. As a market instrument, Heartbeam Inc. Warrants add a layer of flexibility and potential leverage to an investor's portfolio by coupling strategic equity exposure with the dynamic prospects of the medical technology landscape.
“Heartbeam Inc. Warrant's ROE is -987.3%. Explore profitability and growth together.”
Ask for details →Heartbeam Inc. Warrant (ticker: BEATW) is a company listed on NASDAQ in the Unknown sector (Unknown).
The current price is $0.044 with a P/E ratio of -x and P/B of -x.
ROE is -987.32%.